Similar articles

• Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33.

  Streblow DN, Kreklywich CN, Smith P, Soule JL, Meyer C, Yin M, Beisser P, Vink C, Nelson JA, Orloff SL. Streblow DN, et al. Am J Transplant. 2005 Mar;5(3):436-42. doi: 10.1111/j.1600-6143.2004.00711.x. Am J Transplant. 2005. PMID: 15707397
• Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model.

  Fritz NM, Stamminger T, Ramsperger-Gleixner M, Kuckhahn AV, Müller R, Weyand M, Heim C. Fritz NM, et al. Transpl Immunol. 2021 Feb;64:101359. doi: 10.1016/j.trim.2020.101359. Epub 2020 Dec 7. Transpl Immunol. 2021. PMID: 33301898
• Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.

  Koskinen P, Lemstrøm K, Mattila S, Häyry P, Nieminen MS. Koskinen P, et al. Clin Transplant. 1996 Dec;10(6 Pt 1):487-93. Clin Transplant. 1996. PMID: 8996768
• Cytomegalovirus infection and cardiac allograft vasculopathy.

  Koskinen PK, Kallio EA, Tikkanen JM, Sihvola RK, Häyry PJ, Lemström KB. Koskinen PK, et al. Transpl Infect Dis. 1999 Jun;1(2):115-26. doi: 10.1034/j.1399-3062.1999.010205.x. Transpl Infect Dis. 1999. PMID: 11428979 Review.
• Cytomegalovirus host entry and spread.

  Farrell HE, Stevenson PG. Farrell HE, et al. J Gen Virol. 2019 Apr;100(4):545-553. doi: 10.1099/jgv.0.001230. Epub 2019 Feb 7. J Gen Virol. 2019. PMID: 30730289 Review.